Silverarc Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-101,002
| Closed | -$2.72M | – | 79 |
|
|
2024
Q1 | $2.72M | Sell |
101,002
-281,670
| -74% | -$7.59M | 0.76% | 42 |
|
|
2023
Q4 | $11.5M | Buy |
+382,672
| New | +$11.5M | 3.41% | 7 |
|
|
2021
Q3 | – | Sell |
-10,293
| Closed | -$456 | – | 96 |
|
|
2021
Q2 | $456 | Buy |
10,293
+293
| +3% | +$13 | 0.2% | 78 |
|
|
2021
Q1 | $444K | Hold |
10,000
| – | – | 0.24% | 73 |
|
|
2020
Q4 | $548K | Buy |
+10,000
| New | +$548K | 0.32% | 68 |
|